COMMUNIQUÉS West-GlobeNewswire

Shire plc : Director/PDMR Shareholding

01/11/2017 - 16:00

Director/PDMR Shareholding November 1, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging managerial [...]

Affimed to Present Clinical and Preclinical Data on Immune Cell Engagers at ASH

01/11/2017 - 14:17

Heidelberg, Germany, November 1, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that the [...]

uniQure Announces Presentations at the 59th American Society of Hematology (ASH) Annual Meeting

01/11/2017 - 14:10

~ New Nonclinical Data on AMT-061 to be Presented Saturday, December 9, 2017 ~ LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Nov. 01, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy [...]

Novartis presents data at ASH for patients with serious blood disorders like lymphoma, leukemia and sickle cell disease

01/11/2017 - 14:05

Primary results of pivotal Kymriah TM Phase II JULIET study in relapsed/refractory DLBCL Post-hoc sub-analysis of crizanlizumab (SEG101, formerly SelG1) SUSTAIN trial evaluating time to first sickle cell pain crisis [...]

Inivata Announces Strategic Partnership with West Cancer Center

01/11/2017 - 13:30

Inivata Announces Strategic Partnership with West Cancer Center West Cancer Center joins the Inivata Knowledge Accumulation Network (IKAN) Research Triangle Park, NC and Cambridge, UK, November 1, 2017 -- Inivata , a [...]

Align Technology Ongoing Support of Orthodontic and Dental Research

01/11/2017 - 13:30

2018 Grant Application Process Now Open for up to $300,000 in Funding SAN JOSE, CA--(Marketwired - November 01, 2017) - Align Technology, Inc. (NASDAQ: ALGN ) today announced the opening of its 2018 Research Award [...]

Shire plc : Total voting rights

01/11/2017 - 13:00

Total Voting Rights November 1, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and Transparency Rules, notifies [...]

EDAP TMS to Announce Third Quarter 2017 Financial Results on Wednesday, November 15, 2017

01/11/2017 - 12:30

Contact: Blandine Confort Investor Relations / Legal Affairs EDAP TMS SA +33 4 72 15 31 72 bconfort@edap-tms.com Investors: Rich Cockrell CG CAPITAL 877.889.1972 rich@cg.capital Conference Call to Review Results to be [...]

uniQure Announces Third Quarter 2017 Financial Results and Recent Company Progress

01/11/2017 - 12:00

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Nov. 01, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, [...]

RedHill Biopharma and IntelGenx Submit New Drug Application to FDA for RIZAPORT® for Migraines

01/11/2017 - 12:00

RIZAPORT ® is a proprietary oral thin-film formulation of rizatriptan for the treatment of acute migraines A Prescription Drug User Fee Act (PDUFA) date is expected to be set by the FDA for the first half of 2018, if [...]

Enzymatica AB: Sales soar in third quarter

01/11/2017 - 08:00

Enzymatica Interim Report January-September 2017 This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are [...]

Novo Nordisk increased reported operating profit by 5% in the first nine months of 2017

01/11/2017 - 07:30

Reported sales increased by 2% to DKK 83.7 billion (3% in local currencies) Sales within diabetes and obesity care increased by 7% to DKK 69.7 billion (8% in local currencies). Sales of Tresiba ® increased by 117% to [...]

uniQure Announces Multiple Company Presentations at Upcoming November Conferences

31/10/2017 - 21:09

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Oct. 31, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, [...]

Prothena to Report Third Quarter 2017 Financial Results on November 7

31/10/2017 - 21:05

DUBLIN, Ireland, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein [...]

Novavax to Host Conference Call to Discuss Third Quarter 2017 Financial Results on November 7, 2017

31/10/2017 - 21:05

GAITHERSBURG, Md., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its third quarter financial and operating results following the close of U.S. financial markets on Tuesday [...]

Les données provisoires de Vascular Dynamics sur MobiusHD présentées à la conférence TCT montrent des réductions significatives de la pression artérielle systolique ambulatoire à échéance de six mois

31/10/2017 - 18:30

La société a lancé un essai pilote du MobiusHD aux États-Unis et en Europe MOUNTAIN VIEW, Californie, le 31 octobre 2017 (GLOBE NEWSWIRE) - Vascular Dynamics, Inc., une société privée de dispositifs médicaux qui [...]

Oxford BioMedica notes the sBLA submission to FDA for Kymriah(TM) in adult patients with r/r DLBCL

31/10/2017 - 17:02

Oxford BioMedica notes the sBLA submission to FDA for Kymriah(TM) in adult patients with r/r DLBCL Oxford, UK - 31 October 2017 : Oxford BioMedica plc ("Oxford BioMedica" or "the Group") (LSE:OXB), a leading gene and [...]

New Analyses Reinforce Hemodynamic Benefits of Medtronic Evolut(TM) TAVR Platform in Intermediate Risk Aortic Stenosis Patients

31/10/2017 - 15:00

Presented at TCT, Evolut TAVR Platform Showcases Positive Clinical Outcomes in Patients Wanting to Return to More Active Lives DUBLIN and DENVER - October 31, 2017 - Medtronic plc (NYSE:MDT) today presented new clinical [...]

Novo Nordisk A/S - Share repurchase programme

31/10/2017 - 14:26

Bagsværd, Denmark, 31 October 2017 - On 9 August 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]